BioSpace News Archive

10X Genomics is continuing to increase its presence outside of the United States, this time with its first manufacturing facility outside of the country.

BioNTech plans to increase its manufacturing capacity in Africa over time through the supplementation of new manufacturing lines and construction of additional manufacturing sites.

In documents prepared for the meeting, the vaccine demonstrated 90.7% effectiveness for the children in this age group.

On Tuesday morning, Provention Bio announced positive interim results from its Phase I PROVENT study of PRV-101.

Bicycle Therapeutics plc today announced that Genentech, a member of the Roche Group, has exercised an option to initiate a new program, expanding the exclusive strategic collaboration agreement with Bicycle to discover, develop and commercialize novel Bicycle®-based immuno-oncology therapies.

AVROBIO, Inc. today announced the appointment of Essra Ridha, M.D., MRCP, FFPM, as chief medical officer.

Aptose Biosciences Inc. will report financial results for the quarter ended September 30, 2021, and provide a corporate update on Thursday, November 11, 2021, after the close of the market.

Unicycive Therapeutics, Inc. today announced the appointment of Douglas Jermasek as Executive Vice President, Corporate Strategy.

Cybin Inc. today announced that the U.S. Food and Drug Administration (“FDA”) has authorized an Investigational New Drug (“IND”) application to proceed with the Company’s sponsored feasibility study using Kernel’s Flow technology to measure ketamine’s psychedelic effect on cerebral cortex hemodynamics.

9 Meters Biopharma, Inc. today presented pharmacokinetic data on its drug candidate vurolenatide, a proprietary long-acting glucagon-like peptide-1 (GLP-1) agonist in development for short bowel syndrome (SBS), at the American College of Gastroenterology (ACG) 2021 Annual Scientific Meeting, being held in Las Vegas, Nevada through October 27, 2021.